NEW YORK (Reuters Health) - Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.
- MR imaging accurately determines prostate cancer treatment failureWed, 21 May 2008, 17:07:30 EDT
- Rutgers researchers assess severity of prostate cancers using magnetic resonance imagingTue, 10 Aug 2010, 16:16:23 EDT
- Molecular imaging detects recurrent prostate cancerMon, 7 Jun 2010, 0:25:24 EDT
- CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancerThu, 26 Jun 2008, 10:22:16 EDT
- The hot -- and cold -- interventional radiology treatments for recurrent prostate cancerTue, 16 Mar 2010, 10:53:47 EDT